Aardvark Therapeutics, Inc. - Common Stock (AARD)

The company said that the decision was based on certain cardiac observations made during routine safety monitoring in a healthy volunteer study.

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.

Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session.

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Aardvark's lead drug ARD-101 targets PWS and HO with trials underway and funding secured through 2027 after a $94.2 million IPO in February.

Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

The drug treats excessive hunger that often leads to obesity in patients with a rare, genetic disease.

Shares of Kestra Medical, a wearable cardiac device maker, soared in the company's public debut this week. Meanwhile, Discord is said to be in talks for a possible IPO in 2025.

Cybersecurity company SailPoint opened for trading on Thursday, as it returned to the markets more than two years after it went private. It had priced its upsized initial public offering of 60 million shares of its common stock at $23.00 per share.